Neuroleptic malignant syndrome

被引:0
作者
Pillon, Francois [1 ]
机构
[1] 17 Blvd Brosses, F-21000 Dijon, France
来源
ACTUALITES PHARMACEUTIQUES | 2016年 / 55卷 / 553期
关键词
antipsychotic drug; neuroleptic malignant syndrome; pharmacovigilance;
D O I
10.1016/j.actpha.2015.11.032
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Neuroleptic malignant syndrome. Neuroleptic malignant syndrome is a serious and unpredictable drug reaction which is characterised by four symptoms: altered mental functions, fever, muscle rigidity and autonomic dysfunction. The pharmacist must be vigilant when a patient uses neuroleptic or antipsychotic drugs as well as some other medications. (C) 2015 Elsevier Masson SAS. All rights reserved
引用
收藏
页码:48 / 49
页数:2
相关论文
共 5 条
[1]   Neuroleptic malignant syndrome under treatment with antidepressants? A critical review [J].
Assion, HJ ;
Heinemann, F ;
Laux, G .
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 1998, 248 (05) :231-239
[2]   A NEUROLEPTIC MALIGNANTLIKE SYNDROME DUE TO LEVODOPA THERAPY WITHDRAWAL [J].
FRIEDMAN, JH ;
FEINBERG, SS ;
FELDMAN, RG .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1985, 254 (19) :2792-2795
[3]  
Maule E, 2009, CLIN PHARM, V1, P203
[4]  
Stein M SM, 2006, ANAESTHESIA ANALGESI, V3, P786
[5]   Neuroleptic Malignant Syndrome Associated with Atypical Antipsychotic Drugs [J].
Trollor, Julian N. ;
Chen, Xiaohua ;
Sachdev, Perminder S. .
CNS DRUGS, 2009, 23 (06) :477-492